Our solution takes you from single cell or single-nuclei suspension through library prep and sequencing and delivers immediate results via our analysis software, Trailmaker.
For projects past the scale of a single kit. Send us your samples and we run the whole thing end to end, from
barcoding through sequencing to analysis-ready data.
Our solution takes you from single cell or single-nuclei suspension through library prep and sequencing and delivers immediate results via our analysis software, Trailmaker.
For projects past the scale of a single kit. Send us your samples and we run the whole thing end to end, from
barcoding through sequencing to analysis-ready data.
Bukowski K, Kciuk M, Kontek R. Mechanisms of Multidrug Resistance in Cancer Chemotherapy. International Journal of Molecular Sciences. 2020; 21(9):3233. https://doi.org/10.3390/ijms21093233
Chang, X., Zheng, Y. & Xu, K. Single-Cell RNA Sequencing: Technological Progress and Biomedical Application in Cancer Research. Mol Biotechnol 66, 1497–1519 (2024). https://doi.org/10.1007/s12033-023-00777-0
Cheng, B., Yu, Q. & Wang, W. Intimate communications within the tumor microenvironment: stromal factors function as an orchestra. J Biomed Sci 30, 1 (2023). https://doi.org/10.1186/s12929-022-00894-z
Dong C, Wu J, Chen Y, et al. Activation of PI3K/AKT/mTOR Pathway Causes Drug Resistance in Breast Cancer. Front Pharmacol. 2021;12:628690. Published 2021 Mar 15. https://doi.org/10.3389/fphar.2021.628690
Haughton, P.D., Haakma, W., Chalkiadakis, T. et al. Differential transcriptional invasion signatures from patient derived organoid models define a functional prognostic tool for head and neck cancer. Oncogene 43, 2463–2474 (2024). https://doi.org/10.1038/s41388-024-03091-4
Hernández Borrero, L. J., & El-Deiry, W. S. (2021). Tumor suppressor p53: Biology, signaling pathways, and therapeutic targeting. Biochimica et biophysica acta. Reviews on cancer, 1876(1), 188556. https://doi.org/10.1016/j.bbcan.2021.188556
Hu, A., Sun, L., Lin, H. et al. Harnessing innate immune pathways for therapeutic advancement in cancer. Sig Transduct Target Ther 9, 68 (2024). https://doi.org/10.1038/s41392-024-01765-9
Huang Z, Wu T, Liu AY, Ouyang G. Differentiation and transdifferentiation potentials of cancer stem cells. Oncotarget. 2015;6(37):39550-39563. https://doi.org/10.18632/oncotarget.6098
Huang, L., Guo, Z., Wang, F. et al. KRAS mutation: from undruggable to druggable in cancer. Sig Transduct Target Ther 6, 386 (2021). https://doi.org/10.1038/s41392-021-00780-4
Kalpana Ravi, Yining Zhang, Lydia Sakala, et al. Tumor Microenvironment On-A-Chip and Single-Cell Analysis Reveal Synergistic Stromal–Immune Crosstalk on Breast Cancer Progression. Advanced Science (2025) https://doi.org/10.1002/advs.202413457
Laplane, L., Maley, C.C. The evolutionary theory of cancer: challenges and potential solutions. Nat Rev Cancer 24, 718–733 (2024). https://doi.org/10.1038/s41568-024-00734-2
Li, Y., Lim, C., Dismuke, T. et al. Suppressing recurrence in Sonic Hedgehog subgroup medulloblastoma using the OLIG2 inhibitor CT-179. Nat Commun 16, 1091 (2025). https://doi.org/10.1038/s41467-024-54861-3
Ling He, Daria Azizad, Kruttika Bhat, Angeliki Ioannidis, et al. Radiation-Induced Cellular Plasticity: A Strategy for Combatting Glioblastoma bioRxiv 2024.05.13.593985; https://doi.org/10.1101/2024.05.13.593985
Lintz, M., Muñoz, A., & Reinhart-King, C. A. (2017). The Mechanics of Single Cell and Collective Migration of Tumor Cells. Journal of biomechanical engineering, 139(2), 0210051–0210059. https://doi.org/10.1115/1.4035121
Park, S. R., Namkoong, S., Friesen, L., Cho, C. S., Zhang, Z. Z., Chen, Y. C., Yoon, E., Kim, C. H., Kwak, H., Kang, H. M., & Lee, J. H. (2020). Single-Cell Transcriptome Analysis of Colon Cancer Cell Response to 5-Fluorouracil-Induced DNA Damage. Cell reports, 32(8), 108077. https://doi.org/10.1016/j.celrep.2020.108077
Patwardhan MV, Kane TQ, Chiong E, Rahmat JN, Mahendran R. Loss of Glutathione-S-Transferase Theta 2 (GSTT2) Modulates the Tumor Microenvironment and Response to BCG Immunotherapy in a Murine Orthotopic Model of Bladder Cancer. International Journal of Molecular Sciences. 2024; 25(24):13296. https://doi.org/10.3390/ijms252413296
Perini, G.F., Ribeiro, G.N., Pinto Neto, J.V. et al. BCL-2 as therapeutic target for hematological malignancies. J Hematol Oncol 11, 65 (2018). https://doi.org/10.1186/s13045-018-0608-2
Pfeffer, C. M., & Singh, A. T. K. (2018). Apoptosis: A Target for Anticancer Therapy. International journal of molecular sciences, 19(2), 448. https://doi.org/10.3390/ijms19020448
Quail, D., Joyce, J. Microenvironmental regulation of tumor progression and metastasis. Nat Med 19, 1423–1437 (2013). https://doi.org/10.1038/nm.3394
Ratha Mahendran; Mugdha Vijay Patwardhan; Qin Kane Toh; Edmund Chiong Abstract B051: GSTT2 modulates the bladder tumor environment and response to BCG Immunotherapy Cancer Immunol Res (2023) 11 (12_Supplement): B051. https://doi.org/10.1158/2326-6074.TUMIMM23-B051
Saldana-Guerrero, I.M., Montano-Gutierrez, L.F., Boswell, K. et al. A human neural crest model reveals the developmental impact of neuroblastoma-associated chromosomal aberrations. Nat Commun 15, 3745 (2024). https://doi.org/10.1038/s41467-024-47945-7
Shiau, C., Cao, J., Gong, D. et al. Spatially resolved analysis of pancreatic cancer identifies therapy-associated remodeling of the tumor microenvironment. Nat Genet 56, 2466–2478 (2024). https://doi.org/10.1038/s41588-024-01890-9
Song, P., Gao, Z., Bao, Y. et al. Wnt/β-catenin signaling pathway in carcinogenesis and cancer therapy. J Hematol Oncol 17, 46 (2024). https://doi.org/10.1186/s13045-024-01563-4
Spasevska, I., Sharma, A., Steen, C. B., et al. (2023). Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma. Blood advances, 7(23), 7216–7230. https://doi.org/10.1182/bloodadvances.2023010158
Su S, Li X. Dive into Single, Seek Out Multiple: Probing Cancer Metastases via Single-Cell Sequencing and Imaging Techniques. Cancers. 2021; 13(5):1067. https://doi.org/10.3390/cancers13051067
Tufail, M., Jiang, CH. & Li, N. Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches. Sig Transduct Target Ther 10, 227 (2025). https://doi.org/10.1038/s41392-025-02280-1
Wei, X., Chen, Y., Jiang, X., et al. (2021). Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments. Molecular cancer, 20(1), 7. https://doi.org/10.1186/s12943-020-01288-1
Ye, Ying-Hui et al. Identification of tumor heterogeneity associated with KRAS/TP53 co-mutation status in lung adenocarcinoma based on single-cell RNA sequencing. American journal of cancer research vol. 14,2 655-678. 15 Feb. 2024, https://doi.org/10.62347/NXAJ9418
Yuning J. Tang, Haiqing Xu, Nicholas W. Hughes et al. Functional mapping of epigenetic regulators uncovers coordinated tumor suppression by the HBO1 and MLL1 complexes bioRxiv 2024.08.19.607671; https://doi.org/10.1101/2024.08.19.607671
Zhan, Q., Liu, B., Situ, X. et al. New insights into the correlations between circulating tumor cells and target organ metastasis. Sig Transduct Target Ther 8, 465 (2023). https://doi.org/10.1038/s41392-023-01725-9
Zhou J, Tien AC, Alberta JA, et al. A Sequentially Priming Phosphorylation Cascade Activates the Gliomagenic Transcription Factor Olig2. Cell Rep. 2017;18(13):3167-3177. https://doi.org/10.1016/j.celrep.2017.03.003
Li, Q., Li, Z., Luo, T. et al. Targeting the PI3K/AKT/mTOR and RAF/MEK/ERK pathways for cancer therapy. Mol Biomed 3, 47 (2022). https://doi.org/10.1186/s43556-022-00110-2
Koyama S, Nishikawa H. Mechanisms of regulatory T cell infiltration in tumors: implications for innovative immune precision therapies. Journal for ImmunoTherapy of Cancer. 2021;9:e002591. https://doi.org/10.1136/jitc-2021-002591
